12-19440152-T-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_153207.5(AEBP2):​c.453T>A​(p.Asp151Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000239 in 1,497,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 0 hom. )

Consequence

AEBP2
NM_153207.5 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.388
Variant links:
Genes affected
AEBP2 (HGNC:24051): (AE binding protein 2) Predicted to enable transcription coregulator activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within regulation of transcription, DNA-templated. Located in nucleoplasm. Part of ESC/E(Z) complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013116628).
BS2
High AC in GnomAd4 at 24 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
AEBP2NM_153207.5 linkuse as main transcriptc.453T>A p.Asp151Glu missense_variant 1/8 ENST00000266508.14 NP_694939.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
AEBP2ENST00000266508.14 linkuse as main transcriptc.453T>A p.Asp151Glu missense_variant 1/81 NM_153207.5 ENSP00000266508 Q6ZN18-2
AEBP2ENST00000398864.7 linkuse as main transcriptc.453T>A p.Asp151Glu missense_variant 1/91 ENSP00000381840 P1Q6ZN18-1
AEBP2ENST00000538425.5 linkuse as main transcriptc.-16-22358T>A intron_variant 4 ENSP00000444255
AEBP2ENST00000541908.5 linkuse as main transcriptc.-16-22358T>A intron_variant 3 ENSP00000437983

Frequencies

GnomAD3 genomes
AF:
0.000163
AC:
24
AN:
147238
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000253
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000673
Gnomad ASJ
AF:
0.00291
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000180
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000207
AC:
21
AN:
101318
Hom.:
0
AF XY:
0.000143
AC XY:
8
AN XY:
55802
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000471
Gnomad ASJ exome
AF:
0.00220
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000158
Gnomad OTH exome
AF:
0.000324
GnomAD4 exome
AF:
0.000247
AC:
334
AN:
1350692
Hom.:
0
Cov.:
35
AF XY:
0.000236
AC XY:
157
AN XY:
665370
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000614
Gnomad4 ASJ exome
AF:
0.00268
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000235
Gnomad4 OTH exome
AF:
0.000355
GnomAD4 genome
AF:
0.000163
AC:
24
AN:
147238
Hom.:
0
Cov.:
32
AF XY:
0.000195
AC XY:
14
AN XY:
71808
show subpopulations
Gnomad4 AFR
AF:
0.0000253
Gnomad4 AMR
AF:
0.0000673
Gnomad4 ASJ
AF:
0.00291
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000180
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000262
Hom.:
0
Bravo
AF:
0.000159
ExAC
AF:
0.0000908
AC:
9

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 03, 2022The c.453T>A (p.D151E) alteration is located in exon 1 (coding exon 1) of the AEBP2 gene. This alteration results from a T to A substitution at nucleotide position 453, causing the aspartic acid (D) at amino acid position 151 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
20
DANN
Uncertain
0.97
DEOGEN2
Benign
0.051
T;.
Eigen
Benign
-0.42
Eigen_PC
Benign
-0.24
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.70
T;T
M_CAP
Pathogenic
0.84
D
MetaRNN
Benign
0.013
T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.0
N;N
MutationTaster
Benign
1.0
D;N;N
PrimateAI
Pathogenic
0.95
D
PROVEAN
Benign
0.080
N;N
REVEL
Benign
0.064
Sift
Benign
0.041
D;D
Sift4G
Benign
0.79
T;T
Polyphen
0.12
B;.
Vest4
0.067
MutPred
0.16
Loss of sheet (P = 0.1158);Loss of sheet (P = 0.1158);
MVP
0.14
MPC
1.0
ClinPred
0.046
T
GERP RS
4.0
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.6
Varity_R
0.18
gMVP
0.095

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs754445302; hg19: chr12-19593086; API